chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 30.0
Sex: F
Vaccine: MMR
Symptoms: Drug exposure during pregnancy, Fatigue, Pyrexia, Urine human chorionic gonadotropin positive
Clinical narrative: Information has been received from a 30 year old female with a history of adhesions in 1997 who on 17-JUL-2008 was vaccinated with MMR II (lot# not reported). On 21-JUL-2008 the patient experienced fever for 3 consecutive days. It was reported that the patient was always feeling a little tired these days. The patient's tiredness persisted. On 12-AUG-2008, the patient took a home pregnancy test and it was positive (LMP 30-JUN-2008). Follow-up information was received from a healthcare professional updating patient information regarding pregnancy. The patient has had two previous pregnancies, two live births, no birth defects associated with those births, and no miscarriages or stillbirths. Pregnancy was confirmed through a positive urine pregnancy test on 19-AUG-2008 (previously reported as 12-AUG-2008). Estimated delivery date is 23-MAR-2009 (previously reported as 06-APR-2009). Follow-up information was received from a healthcare professional on 26-SEP-2008 indicating that the patient went to the clinic for a pregnancy test only. No other information is available. This is in follow-up to report (s) previously submitted on 5/29/2009.  Information has been received from a 30 year old female with a history of adhesions in 1997 who on 17-JUL-2008 was vaccinated with MMR II (lot# not reported).  On 21-JUL-2008 the patient experienced fever for 3 consecutive days.  It was reported that the patient was always feeling a little tired these days.  The patient's tiredness persisted.  On 12-AUG-2008, the patient took a home pregnancy test and it was positive (LMP 30-JUN-2008).  Follow-up information was received from a healthcare professional updating patient information regarding pregnancy.  The patient has had two previous pregnancies, two live briths, no birth defects associated with those births, and no miscarriages or stillbirths.  Pregnancy was confirmed through a positive urine pregnancy test on 19-AUG-2008 (previously reported as 12-AUG-2008).  Estimated delivery date is 23-MAR-2009 (previously reported as 06-APR-2009).  Follow-up information was received from a healthcare professional on 26-SEP-2008 indicating that the patient went to the clinic for a pregnancy test only.  Follow-up information has been received from a nurse practitioner who reported that the patient was vaccinated with the first dose of MMR II on "16-JUL-2009" (previously reported as 17-JUL-2008).  It was unknown if the patient had taken any medications during pregnancy.  It was noted that the vaccination occurred 2 weeks after the patient's last menstrual period.  The patient's last menstrual period was on 30-JUN-2008.  The nurse practitioner reported that the patient had moved out of state.  Additional information is not expected.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Cellulitis
Clinical narrative: Information has been received from a medial assistant concerning a 4 year old male who received the second dose of MMR II (rHA) (Lot # 655380/1326F), 0.5 ml SQ on 04-Aug-2008. The patient received his first dose of MMR II on 02-Sep-2005. On 06-Aug-2008, the patient developed cellulitis. The patient was seen on 07-Aug-2008 and was prescribed AUGMENTIN. The patient had an appointment today but did not show up for the follow-up. It is reported that the patient is recovering from the event. Unspecified medical attention was sought. No product quality complaint was involved. A lot check has been requested. Lot check results for 655380/1326F: A standard lot check investigation was performed. All in-process quality checks for the lot number in question were satisfactory. The lot met the requirements of the center and was released. Additional information has been requested.
Age: 5.0
Sex: F
Vaccine: MMR
Symptoms: Allergy to vaccine, Injection site cellulitis, Injection site erythema, Injection site warmth, Rash
Clinical narrative: Information has been received from a medical assistant concerning a 5 year old male patient with no known allergies or pertinent medical history who on 12-AUG-2008 was vaccinated SQ with a first 0.5ml dose of MMR II (lot # 655380/1326F). There was no concomitant medication. Subsequently, on 14-AUG-2008 the patient developed cellulitis. Medical attention was sought, the patient was seen. There were no lab studies performed. The patient was prescribed AUGMENTIN. At the time of the report, the patient had not recovered. There was no product quality complaint involved. Additional information has been requested. A lot check has been requested. The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory. The lot met the requirements of the center and was released by the regulatory agency. Follow up information was received from the physician who reported that the patient was a female with asthma and a history of pre-term birth (at 35 weeks) who in the afternoon of 12-AUG-2008 was vaccinated SQ in her left leg with a first dose of MMR II (rHA) (lot# 655380/1326F). There was no illness at the time of vaccination. At 13:40 of 12-AUG-2008, within 48 hours, the patient's injection site was red, warm to touch which was initially treated as left thigh cellulitis. The patient was treated with AUGMENTIN. Within 24 hours her cellulitis improved, then worsened. On the 4th day post injection, antibiotic was changed to clindamycin, the patient was also seen in the emergency room (ER). The patient presented at the ER with a red circular area on her left thigh. She denied pain, fever and no distress was noted. It was also reported that the patient had experienced cellulitis since 14-AUG-2008. The patient was treated with IV ROCEPHIN 1gm. The patient was told that it was an allergic reaction to MMR II. The patient was advised to continue AUGMENIN as prescribed by PCF, alternate MOTRIN and TYLENOL for fever. The patient was directed to return to the ER if she experienced increased erythema, drainage or other concerns. No any laboratory or diagnostics tests were performed. On 25-AUG-2008, 13 days post injection, the patient developed a rash that started from her cheeks and spread downward. At the time of this report, the patient recovered. Additional information is not expected. This is one of several reports from the same source.
Age: 1.0
Sex: F
Vaccine: MMR, PNC, VARCEL
Symptoms: Body temperature increased, Pyrexia, Rash morbilliform, Rhinorrhoea
Clinical narrative: Information has been received from a physician concerning a 12 month old female with no medical history or allergies, who on 05-AUG-2008 was vaccinated with a dose of MMR. Concomitant suspect vaccine therapy included VARIVAX (Merck). Other concomitant vaccine therapy included (PREVNAR). The physician reported that on 15-AUG-2008 the patient developed a measles like rash, a runny nose and fever of 101.9 F. Treatment (unspecified) included supportive measured for the patient's comfort. The patient sought medical attention in the office. At the time of this report the outcome was reported as recovering. A product quality complaint was not involved. Additional information has been requested.
Age: 5.0
Sex: F
Vaccine: MMR
Symptoms: Urticaria
Clinical narrative: Information has been received from a patient's mother concerning a 5 year old female with peanut oil allergy who in approximately 2006 was vaccinated with the first dose of MMR. The patient's mother reported that in approximately 2006 the patient broke out in hives a week after getting vaccinated. The patient's mother did not want to provide any specific information. It is unknown if the patient sought medical attention. The outcome is unknown. No additional information is expected.
Age: 1.5
Sex: M
Vaccine: MMR
Symptoms: Body temperature increased, Irritability, Pallor, Pyrexia, Rash erythematous
Clinical narrative: Information has been received from a certified medical assistant concerning an 18 month old male, who is otherwise healthy, who on 23-JUL-2008 at 10:30 was vaccinated SQ with the first dose of MMR II (rHA) (lot # 660202/0451X) in the right thigh. There was no concomitant medication. On 02-AUG-2008 the patient experienced "viral rash". The patient was seen in the ER but was not admitted to the hospital. The course of treatment and the outcome were not reported. A product quality complaint was not involved. Follow-up information has been received on 29-SEP-2008 from a B-vaccine form and emergency room records. It was reported that the patient has an amoxicillin allergy and history of vomiting and there was no illness at the time of immunization. On 30-JUL-2008, the patient had a fever to 102. On 02-AUG-2008, the patient had a red, macular, blanching, diffuse rash on face and torso (spreading out) and was seen in the emergency room. The patient was described as very fussy, the patient's temperature was 36.9 C. The patient was diagnosed with a viral rash/ after MMR II (rHA) rash. The patient was treated with TYLENOL (dose, and duration not reported) and to follow-up with the primary care physician. The outcome was reported as recovered/resolved (date not reported). No further information is available.
Age: 1.5
Sex: M
Vaccine: MMR
Symptoms: Rash macular, Viral rash
Clinical narrative: Information has been received from a certified medical assistant concerning an 18 month old male, who is otherwise healthy, who on 23-JUL-2008 at 10:30 was vaccinated SQ with the first dose of MMR II (rHA) (lot # 660202/0451X) in the right thigh. There was no concomitant medication. On 02-AUG-2008 the patient experienced "viral rash". The patient was seen in the ER but was not admitted to the hospital. The course of treatment and the outcome were not reported. A product quality complaint was not involved. Follow-up information has been received on 29-SEP-2008 from a B-vaccine form and emergency room records. It was reported that the patient has an amoxicillin allergy and history of vomiting and there was no illness at the time of immunization. On 30-JUL-2008, the patient had a fever to 102. On 02-AUG-2008, the patient had a red, macular, blanching, diffuse rash on face and torso (spreading out) and was seen in the emergency room. The patient was described as very fussy, the patient's temperature was 36.9 C. The patient was diagnosed with a viral rash/ after MMR II (rHA) rash. The patient was treated with TYLENOL (dose, and duration not reported) and to follow-up with the primary care physician. The outcome was reported as recovered/resolved (date not reported). No further information is available.
Sex: F
Vaccine: MMR
Symptoms: Measles antibody negative
Clinical narrative: Information has been received from a female nursing student who was vaccinated in the past (unsure of how many doses she was given) with MMR II. The reporter is now presenting with a low measles titer. No adverse reactions were reported, no other information was available (did not have time to talk on the phone to answer questions). Additional information has been requested.
Age: 36.0
Sex: F
Vaccine: MMR
Symptoms: Antibody test negative
Clinical narrative: Information has been received from a registered nurse concerning a 36 year old female with drug reaction to NORGESIC FORTE which causes nausea. The nurse mentioned the patient received MMR II as a child and titers were found to be negative on 30-JUL-2008. The lot number of this MMR II dose is unknown. It is unknown if the patient received a second dose of MMR II as a child. On 04-AUG-2008, the patient was given a subcutaneous dose of 0.5 mL MMR II (rHA) (Lot # 658582/0043X) and another subcutaneous dose of 0.5 mL MMR II (rHA) (Lot # 658582/0043X) on 26-AUG-2008. The patient was not experiencing any known symptoms from receiving the dose on 26-AUG-2008 early. The patient sought medical attention and had an office visit. There was no product quality complaint. Additional information has been requested.
Sex: F
Vaccine: MMR
Symptoms: Encephalitis
Clinical narrative: Information has been received from a consumer concerning a female child who was vaccinated with a dose of MMR II on an unspecified date. Subsequently the patient experienced encephalitis on an unspecified date. The outcome was not reported. Upon internal review, encephalitis was determined to be an other important medical event. This is one of several reports received from the same source. No further information is available.
Sex: M
Vaccine: MMR
Symptoms: Deafness
Clinical narrative: Information has been received from a consumer concerning a male child who was vaccinated with a dose of MMR II on an unspecified date. Subsequently the patient lost his hearing on an unspecified date. The outcome was not reported. Upon internal review, lost hearing was determined to be an other important medical event. This is one of several reports received from the same source. No further information is available.
Sex: U
Vaccine: MMR, VARCEL
Symptoms: Convulsion
Clinical narrative: Information has been received from a consumer via the internet concerning her healthy toddler child who on an unspecified date was vaccinated with a dose of MMR II. Concomitant therapy included VARIVAX vaccinated at the same time. Subsequently, "after receiving the vaccination at the same time as the VARIVAX", the patient developed a seizure. The outcome was not provided at this time. it was not specified if the patient sought medical attention or not. Upon internal review, seizure was considered to be other important medical event. This is one of several reports received from the same source. Additional information has been requested.
Age: 0.44
Sex: F
Vaccine: MMR
Symptoms: Convulsion, Muscle spasms, Nervous system disorder, Pyrexia, Similar reaction on previous exposure to drug
Clinical narrative: Information has been received from a physician concerning a now 29 year old female patient, who in 1980, at age one was vaccinated with the first dose of MMR II with other unspecified vaccines. After receiving the vaccine, the patient experienced fever and had to be hospitalized. With the second dose, the physician separated the vaccines and just gave the MMR II and the patient had a more severe reaction like seizure and had to be hospitalized, after that the patient developed spasms and neurologic problems. Following the vaccination, the patient experienced facial tick for about a year. The patient sought unspecified medical attention. At the time of reporting, the patient's outcome was unknown. Additional information has been requested. This is in follow up to report(s) previously submitted on 5/29/2009. Follow-up information was received from the physician who reported that she had no additional information regarding these events as they occurred over 25 years ago and also indicated that this was all the patient knew as well. Additional information is not expected.
Age: 0.44
Sex: F
Vaccine: MMR
Symptoms: Tic
Clinical narrative: Information has been received from a physician concerning a now 29 year old female patient, who in 1980, at age one was vaccinated with the first dose of MMR II with other unspecified vaccines. After receiving the vaccine, the patient experienced fever and had to be hospitalized. With the second dose, the physician separated the vaccines and just gave the MMR II and the patient had a more severe reaction like seizure and had to be hospitalized, after that the patient developed spasms and neurologic problems. Following the vaccination, the patient experienced facial tick for about a year. The patient sought unspecified medical attention. At the time of reporting, the patient's outcome was unknown. Additional information has been requested. This is in follow up to report(s) previously submitted on 5/29/2009. Follow-up information was received from the physician who reported that she had no additional information regarding these events as they occurred over 25 years ago and also indicated that this was all the patient knew as well. Additional information is not expected.
Age: 4.0
Sex: F
Vaccine: MMR
Symptoms: Computerised tomogram normal, Convulsion, Electroencephalogram abnormal, Nuclear magnetic resonance imaging normal
Clinical narrative: Information has been received from a physician concerning an approximately 5 year old female who in November 2007 (when she was 4 years old), was vaccinated with her second dose of MMR II (Lot # not reported). Concomitant therapy included DTaP (manufacturer unspecified) (Lot # not reported) received in October 2007. In June 2008, the patient had a "twilight" seizure where she was going "in and out" of her sleep cycle. It was originally thought that she had sleep apnea. The patient had seen an ear, nose, and throat (ENT) specialist and a neurologist. Last month (approximately July 2008) the patient had another seizure. The patient sought medical attention and went to the emergency room and was put on an unspecified seizure medication but the patient did not react well to it (unspecified reaction). On an unspecified date the patient had a magnetic resonance imaging (MRI) which was normal, a computed axial tomography (CT) scan which was normal, and an electroencephalogram (EEG) which was abnormal. No product quality complaint was involved. Upon internal review, "twilight" seizure and seizure were considered to be other important medical events. No further information is expected.
Age: 1.1
Sex: M
Vaccine: HEPA, MMR, VARCEL
Symptoms: Urticaria
Clinical narrative: Information has been received from a physician concerning a male who on 26-AUG-2008 was vaccinated with the first dose of MMR II. Suspect therapy included VARIVAX (MSD). Concomitant therapy included HAVRIX. By time the patient returned home he had developed "hives" on his arms and legs. Medical attention was sought by calling the physician's office. The patient was referred to an allergist. There were no diagnostic or laboratory tests performed. No product quality complaint involved. Additional information has been requested.
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Erythema
Clinical narrative: Information has been received from a physician concerning a male who was vaccinated with MMR II. The patient developed erythema after getting MMR II and VARIVAX (MSD) on the same day. Lot number was not provided. It was reported that the patient recovered from the event (date unspecified by reporter). Unspecified medical attention was sought. No product quality complaint involved. Additional information has been requested.
Age: 39.0
Sex: M
Vaccine: MMR
Symptoms: Mumps, Mumps antibody test positive, Parotid gland enlargement
Clinical narrative: Information has been received from a nurse at a health department concerning a 39 year old male, who on 17-JUL-2008, was vaccinated with MMR II. On 10-AUG-2008, the patient experienced swelling of his jaw after receiving the vaccine. The patient had a history of blocked salivary glands and thought it was related to that. He went to his physician on 12-AUG-2008 and the physician said he had parotid swelling. The physician put the patient on amoxicillin in case it was related to a blocked salivary gland. The physician later told the health department nurse that he suspected a case of mumps. A mumps titer was drawn, which revealed a viral antibody of 80 for IgM and 4.41 for IgG. When the health department tried to contact the patient he was on vacation with his family. When he was seen again, the patient had already recovered (date unspecified). No product quality complaint involved. Additional information has been requested.
Sex: M
Vaccine: MMR
Symptoms: Measles antibody negative
Clinical narrative: Information has been received from a nurse concerning a male with no known allergies and reported no pertinent medical history who was vaccinated with two doses of MMR II as a child (dates, dose, route and lot numbers are not known). Concomitant therapy included cholesterol medication (unspecified). The nurse reported that the patient had a negative measles titer (less than 0.91U). The patient sought medical attention at an office visit. The outcome was not reported. A product quality complaint was not involved. Additional information has been requested.
Age: 23.0
Sex: M
Vaccine: MMR
Symptoms: Measles antibody negative
Clinical narrative: Information has been received from a physician concerning a 23 year old male with no known allergies or medical history who in approximately 1986 (15 months old) and approximately 1995 (10 years old) was vaccinated with the first and second doses respectively of MMR II (dose and route not reported). There was no concomitant medication. On 06-JUN-2006, it was discovered that the patient had a negative measles titer. It became an issue when the patient applied to medical school. The patient did not seek medical attention. A product quality complaint was not involved. Additional information has been requested.
Age: 14.0
Sex: F
Vaccine: MMR
Symptoms: Body temperature increased, Pyrexia, Viral infection
Clinical narrative: Information has been received from a consumer concerning a 14 year old female who was vaccinated with a dose of MMR II when the patient was a preschooler (date, dose and route unspecified). The patient's mother reported that the patient developed a fever of 107 F after receiving MMR II within an unspecified period of time. The patient sought medical attention at an office visit. The patient fully recovered (date unspecified). A product quality complaint was not involved. Follow-up information was received from the physician's office staff who stated that the office did not report the adverse event and does not feel it was warranted. The event occurred over 13 years ago and the patient had a virus accompanied with a fever. No further information is expected.
Age: 1.0
Sex: M
Vaccine: MMR, PNC, VARCEL
Symptoms: Urticaria
Clinical narrative: Information has been received from a physician concerning a 12 month old male with a history of kidney transplant waiting list, feeding tube, congenital hip dislocation and congenital urinary anomalies, who on 30-JUL-2008 was vaccinated with the first dose of MMR II. Suspect therapy included the first dose of VARIVAX. Concomitant therapy included the third dose of PREVNAR and does not believe to be on immunosuppressive agents. The patient developed hives within 24 hours of the vaccination. The patient was not seen in the office for hives. The child's mother called and reported he was "covered from head to toe with red welts". He was treated with diphenhydramine hydrochloride at a dose of 1/2 teaspoon every 6 hours. The hives resolved within 24 hours of treatment. He is being sent to an allergist for testing. No laboratory tests were performed. No product quality complaint was involved. Additional information has been requested.
Age: 4.0
Sex: F
Vaccine: DTAPIPV, MMR
Symptoms: Mumps antibody test negative
Clinical narrative: Information has been received from a patient's mother concerning her 7.5 year old daughter with no allergies or pertinent medical history who was vaccinated with all three doses of MMR II SQ. The patient has received titer test revealing that she is not protected from the mumps at this time. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been received from a patient's mother indication that the physician will give the patient another dose of MMR II because the mumps virus vaccine (MSD) is not available until 2009. Additional information has been received from a physician concerning the 7 year old female patient who on 16-MAY-2002 was vaccinated with the first dose of MMR II (lot# 636580/1273L, is valid for VARIVAX, not MMR II, on 26-SEP-2005, was vaccinated with the second dose of MMR II (Lot# 648677/0555P). On 26-SEP-2005, the patient also received DTAP-IPV. On 16-MAY-2002, the patient also received Varicella virus vaccine live (manufacturer unknown). In August 2008, the patient has a Mumps IgG testing, and the outcome was negative. The patient requested Mumps vaccine. No further information is available.
Sex: F
Vaccine: MMR
Symptoms: Measles antibody negative, Pyrexia, Rash
Clinical narrative: Information has been received from a nurse concerning an adult female who on 29-AUG-2008 was vaccinated with a booster dose of MMR II. On 10-SEP-2008, 12 days after receiving MMR II, she developed a high fever and rash on her torso. The vaccine was a booster because the woman works around unvaccinated infants and had a low measles titer. It is reported that the women has not recovered. She sought medical attention with an appointment with her physician. No product quality complaint involved. Additional information has been requested.
Age: 42.0
Sex: M
Vaccine: MMR
Symptoms: Rubella antibody negative
Clinical narrative: Information has been received from a nurse concerning a 42 year old male with allergy to Prozac who received dose 1 of MMR II as a child tested negative for rubella titers. His measles and mumps titers were high. The patient is in nursing school and on 02-JAN-2008 he received a second dose of MMR II (Lot # 655270/1409F). Concomitant therapy included tuberculin purified protein derivative vaccination given during the same visit as the second vaccination of MMR II. On 18-AUG-2008 his rubella titer was still negative. No other details given. Unspecified medical attention was sought. No product quality complaint was involved.
Age: 30.0
Sex: F
Vaccine: MMR
Symptoms: Mumps antibody test negative
Clinical narrative: Information has been received from a registered nurse (RN) concerning a 30 year old female with no allergies or medical history who was vaccinated with a dose of MMR II as a child (date and dose not reported). There was no concomitant medication. On 05-SEP-2008 the patient had a titer drawn (for school entrance) and was found not to have immunity for mumps. No adverse effects were reported. The patient sought medical attention at the office. There was no product quality complaint involved. Additional information has been requested.
Age: 48.0
Sex: F
Vaccine: MMR, MNQ
Symptoms: Red blood cell sedimentation rate increased
Clinical narrative: Information has been received from a pharmacy student concerning a 48 year old female with drug reactions/allergies to NSAIDS, lidocaine, morphine, Vicodin, statins and tomatoes and a medical history of glaucoma, depression, insomnia, and breast mass, who in the summer of 2008, was vaccinated with MMR II. Concomitant therapy included MENACTRA. the patient had an increased sedimentation rate after vaccination with MMR II. The sed rate increased from the 60's to 188. It was reported that the patient has not yet recovered. No product quality complaint involved. Additional information has been requested.
Sex: M
Vaccine: MMR
Symptoms: Measles post vaccine
Clinical narrative: Information has been received from a consumer concerning her 35 year old son who received MMR II when he was a young child. It was reported that he developed measles several days after vaccination. No product quality complaint involved. This is one of several reports from the same source. Additional information has been requested.
Age: 36.0
Sex: F
Vaccine: MMR
Symptoms: Antibody test negative, Expired drug administered, Measles antibody negative, Mumps antibody test negative, Rubella antibody negative
Clinical narrative: Information has been received from a registered nurse concerning a 36 year old female who has received two doses of MMR II in the past (date not reported) and still has a low titer for measles, mumps and rubella (date not reported). On 18-SEP-2008, the patient was vaccinated with a "booster" dose of MMR II  that was expired. it is unknown if the patient sought medical attention. A product quality complaint was not involved. Additional information has been requested.
Age: 1.3
Sex: M
Vaccine: MMR
Symptoms: Erythema, Urticaria
Clinical narrative: Information has been received from a consumer, who is a nurse, concerning her 15 month old male son with no medical history or allergies who on 09-SEP-2008 was vaccinated with the first dose of MMR II. There was no concomitant medication. On approximately 10-SEP-2008 (36 hours post-vaccination), the patient experienced redness in the face and hives that started on the back and spread all over the patient's body. The nurse applied BENADRYL topically and after 24 hours the rash went away. The patient did not seek medical attention. The outcome was reported as recovered/resolved. A product quality complaint was not involved. Additional information has been requested.
Age: 5.0
Sex: M
Vaccine: MMR
Symptoms: Rash, Rash morbilliform
Clinical narrative: Information has been received from a certified medical assistant (CMA) concerning a 5 year old male who around the second or third week of August 2008, was vaccinated with the second dose of MMR II. On 25-SEP-2008, the CMA reported that the patient developed a rash and that rash may be a measles rash. The parent called the office but at the time of the report had not been seen yet in the office. No lab or diagnostic studies were performed. At the time of the report the patient's outcome was reported as not recovered/not resolved. A product quality complaint was not involved. Additional information has been requested.
Age: 20.0
Sex: F
Vaccine: MMR
Symptoms: Mumps antibody test negative
Clinical narrative: Information has been received from a physician concerning a 19.5 year old female patient with penicillin and AUGMENTIN allergy who had two doses of MMR II (1990-1992) and had a low titer for mumps. No other details at the time of this report. The outcome was unknown. Additional information has been requested.
Age: 3.0
Sex: M
Vaccine: MMR
Symptoms: Pyrexia, Rash
Clinical narrative: Information has been received from a consumer concerning her 3 year old son with no pertinent medical history or allergies who on 27-AUG-2008 was vaccinated with his first dose of MMR II (lot# not available) in the arm. There was no concomitant medication. On 03-SEP-2008 "1 week after receiving the vaccination" the patient experienced rash under his arms and a fever. The patient recovered from the rash " less than a week after the rash appeared." No labs or diagnostic studies were performed. There was no product quality complaint. (Consumer declined demographic information or her son's physician's information). No further information was given. Additional information has been requested.
Age: 34.0
Sex: F
Vaccine: HEP, HEPAB, MMR, TTOX
Symptoms: Drug exposure during pregnancy, Inappropriate schedule of drug administration, Metrorrhagia, Ultrasound pelvis normal, Urine human chorionic gonadotropin positive
Clinical narrative: Information has been received from a licensed practical nurse concerning a 34 year old pregnant female with seasonal allergy and thyroid disorder but not on supplements, who on 30-JUL-2008, was vaccinated with the first dose of 0.5 ml MMR II (rHA) (lot # 657244/0527U) in the left upper arm. Concomitant therapy also given on 30-JUL-2008 included TWINRIX, ENGERIX-B. The patient was vaccinated with the second dose of MMR II (rHA) (lot # 659782/0842X) on 03-SEP-2008, in the left upper arm. Concomitant therapy included FLONASE and ENGERIX-B also given on 03-SEP-2008. The nurse states that the patient had been given the VIS vaccine information sheet before getting vaccinated. On 02-OCT-2008, the patient called the doctor's office yesterday stating she had taken a home pregnancy urine test which was positive. The patient's first day of her last menstrual period was 15-AUG-2008. Estimated date of delivery was 22-MAY-2009. No product quality complaint involved. Follow-up information was received. On 02-NOV-2008, the patient experienced spotting. She was seen by the OB/GYN physician. A pelvic ultrasound was performed which was reported as normal. Additional information has been requested.
Sex: M
Vaccine: MMR
Symptoms: Measles antibody positive, Mumps antibody test positive, Rubella antibody negative
Clinical narrative: Information has been received from a physician concerning a male patient with no medical history and no drug reactions/allergies who on an unspecified date ("many years ago") was vaccinated with a dose of MMR (dose frequency, route, lot# not reported). No concomitant medications were reported. The physician reported that this patient only had one dose of MMR and now has a negative or low titer to Rubella. The titers for measles and mumps were adequate. No symptoms reported. There was no product quality complaint. No further information is available.
Age: 1.0
Sex: U
Vaccine: MMR
Symptoms: Rash, Rash morbilliform
Clinical narrative: Information has been received from a nurse at a physician's office that a "12 month old" patient with no medical history, received a dose of MMR II, injection (dose and lot number not provided) on approximately 03-OCT-2008 ("2 weeks ago"). The patient broke out in a rash "yesterday" on approximately 16-OCT-2008. The mother of the patient stated that it looks like measles, however did not come to the office for a check up. No fever reported. No laboratory diagnostic tests were performed. There was no product quality complaint. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: HEPA, MMR, VARCEL
Symptoms: Rash
Clinical narrative: Information has been received from a physician concerning a 12-month-old female who in September 2008, was vaccinated with MMR II, Hep A (manufacturer unknown), and VARIVAX (Merck) (MSD). "About 3-4 days after receiving shot" the patient developed a severe rash and went to the hospital, but was not admitted. The patient was prescribed BENADRYL. At the time of this report, the patient was recovering. No product quality complaint was involved. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Mumps antibody test negative
Clinical narrative: Information has been received from a pharmacist concerning a patient who was vaccinated with MMR II. It was reported that the patient was given MMR II in the past as a child and had low mumps titers. No product quality complaint was involved. No other information was reported. No further information is available.
Sex: M
Vaccine: MMR
Symptoms: Attention deficit/hyperactivity disorder, Malaise
Clinical narrative: Information has been received from a consumer concerning her older son who on an unspecified date was vaccinated with a dose of MMR II (lot number, injection site and route not reported). The consumer reported that her son became very ill after his DPT/MMR (manufacturer not reported) shots. The consumer (patient's mother) would always question if that was part of his attention deficit/hyperactivity disorder (ADHD) issue. No further information is available.
Age: 31.0
Sex: F
Vaccine: MMR
Symptoms: Accidental exposure, Hypoaesthesia facial
Clinical narrative: Information has been received from a 31 year old female licensed practical nurse with no medical history or allergies who on an unspecified date when drawing up a dose of MMR II (rHA) (lot # 657638/1669U) a small amount splashed on the patient's face between the nose and eye. There was no concomitant medication. The patient did not feel that any of the vaccine got in the eye. It was reported that where the patient was splashed it felt different "perhaps numb". The patient reported rubbing the site and perhaps rubbed it too much. The patient sought unknown medical attention. The patient did not wish to be followed-up with. The outcome was reported as not recovered. A product quality complaint was not involved. No further information is available.
Age: 1.0
Sex: F
Vaccine: HEPA, MMR, PPV, VARCEL
Symptoms: Rash morbilliform
Clinical narrative: Information has been received from a consumer concerning a 1 year old female who on 10-OCT-2008 was vaccinated via injection with MMR II. Secondary suspect therapy included VARIVAX (MSD), PNEUMOVAX 23 (mfr unknown) and VAQTA (mfr unknown). The caller stated that her baby received her MMR II vaccine and (8-10 days later) is now covered in what looks like a measles type rash. The caller did consult the physician who stated that it could be a reaction to MMR II, however did not specify whether it was measles. The patient was considered to be not recovered. The patient sought medical attention and consulted a physician. There was no product quality complaint. No further information is expected.
Sex: M
Vaccine: MMR
Symptoms: Injection site swelling
Clinical narrative: Information has been received from a consumer concerning his son who was vaccinated with a dose of MMR II. Subsequently the patient developed spectrum and swelling at the injection site. No medical attention was sought. At the time of this report, 03-NOV-2008, the outcome was unknown. Additional information is not expected.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Mumps, Mumps antibody test positive
Clinical narrative: Information has been received from a nurse concerning a male who was vaccinated with both doses of MMR II and subsequently, the patient developed mumps. The patient sought medical attention from office. Follow-up information received from a nurse concerning a 6 year old male who was vaccinated with two doses of MMR II which were administered on schedule. Subsequently the patient developed mumps. On 25-OCT-2008, serum mumps immunoglobulin G antibody test was performed with result positive. On 29-OCT-2008, serum mumps immunoglobulin M antibody test was performed with result positive. Subsequently, the patient recovered from mumps. Follow-up information has been received from a physician concerning a 6 year old male who on 05-JUL-2003 was vaccinated S.C. with the first dose of MMR II (HSA) (lot #: 645264/0099N) and on 13-APR-2006 was vaccinated S.C. the second dose of MMR II (HSA) (lot #: 650099/0582R). On 23-OCT-2008, the patient developed mumps with elevated mumps IgM 80(ref <10). On approximate 06-Nov-2008, 2 weeks later, it was reported by phone that the patient recovered from mumps. No further information is available.
Sex: U
Vaccine: MMR
Symptoms: Adverse event
Clinical narrative: Information has been received from a patient who was vaccinated with MMR II (route and site not reported). The patient had a previous experience with MMR II. No further information is available.
Age: 1.3
Sex: M
Vaccine: MMR, MMRV, VARCEL
Symptoms: Electroencephalogram, Pyrexia, Tremor
Clinical narrative: Information has been received from a patient's mother concerning her 15 month old son with hypersensitivity to Amoxicillin who on 31-JAN-2006 was vaccinated with a first dose of MMR II. Concomitant therapy included VARIVAX and PROQUAD. On approximately 15-FEB-2006, "two weeks after receiving MMR II", the patient was shaking for about fifteen minutes. The patient was not hospitalized but went to the hospital to have a test done to monitor the patient's brain activity. The test showed that the patient did not have a seizure and it could have been that the patient had a fever. On an unspecified date, the patient recovered. The patient was not going to get the booster. No further adverse effect information was provided. No additional information is available.
Sex: U
Vaccine: HEP, MMR
Symptoms: Adverse event
Clinical narrative: Information has been received from a nurse concerning a patient who in 2007 was vaccinated with a dose of MMR II, RECOMBIVAX HB (MSD) (lot # 625096/1367E and lot # 626441/0600H), VARIVAX (Merck) (MSD) (lot # 628036/1251H). The patient developed an unknown adverse experience after received the vaccines. The patient sought medical attention. Additional information has been requested.
Age: 31.0
Sex: F
Vaccine: MMR, MNQ, TDAP
Symptoms: Headache, Rash, Rash maculo-papular, Rash pruritic
Clinical narrative: Information has been received from a nurse practitioner concerning a 31 year old female student with depression and no drug reaction or allergy who at 15:37 on 26-SEP-2008 was vaccinated with the first dose of MMR II (lot # 656668/1307U), SQ, 0.5ml in the right arm, MENACTRA (U2731AA), 0.5ml, IM in the right deltoid and ADACEL (C2766AA), 0.5ml, IM in the left deltoid. Concomitant therapy included olanzapine and citalopram-antidepressants. On 07-OCT-2008 (previously reported on 08-OCT-2008) the patient reported that she had a headache and took aspirin, On 09-OCT-2008 the patient reported that she awoke with a generalized itchy maculopapular rash on her arms, legs, and trunk of body. The patient was seen and was given ZYRTEC and ATARAX. The patient recovered in a few days. The patient did not do any lab diagnostics. Follow up information received from the nurse practitioner stated that the patient needed medical treatment for the rash and headache and did not have a life-threatening illness. It was reported that the patient was vaccinated with a second dose of MMR II (date not reported) and  the patient had no problems. The nurse practitioner reported that the patient's reaction probably had nothing to do with the first dose of MMR II. No further information is available.
Age: 2.0
Sex: F
Vaccine: MMR
Symptoms: Adverse reaction
Clinical narrative: Information has been received from a nurse concerning a female patient who on 24-DEC-1999 was vaccinated with a dose of MMR II (lot #625634/0028H). Secondary suspected therapy included a dose of RECOMBIVAX HB (lot # 625096/1367E) on 06-APR-1998, a dose of RECOMBIVAX HB (lot # 625096/1367E) on 21-MAY-1998, and a dose of VARIVAX (lot # 628036/1251H) on 25-JAN-1999. The patient was suffering from a number of symptoms which may be related to "over-vaccination" after administration of the above vaccines. The nurse didn't know the specific symptoms. The child was adopted from another country so the child's vaccination history prior to starting at the physician's office was not known. The patient was brought to visit office. At the time of reporting, the patient had not recovered. Follow-up information was received from a physician, who stated that he had not seen the patient since 1999, and he was not aware of any adverse reaction to MMR II. Additional information has been requested.
Sex: M
Vaccine: MMR
Symptoms: Measles antibody negative
Clinical narrative: Information has been received from a registered nurse concerning a male adult patient who on 20-NOV-2007 was vaccinated subcutaneously with a 0.5ml dose of MMR II and on 26-FEB-2008 received subcutaneously a second 0.5ml dose of MMR II. The physician stated that the patient had titers drawn on 24-Feb-2008 and 04-APR-2008, both titers for measles were negative. The patient sought unspecific medical attention. At the time of the report the patient status was unknown. Additional information has been requested.
Sex: F
Vaccine: MMR
Symptoms: Arthralgia, Lymphoedema, Pyrexia
Clinical narrative: Information has been received from a Doctor of pharmacy concerning an adult female patient who in September 2008 was vaccinated with a dose of MMR II (Lot# 654335/0449F) by SQ route. After vaccination, the patient developed lymphedema, fever and polyarthralgia. The patient sought medical attention. The patient recovered from lymphedema and fever, but the patient's polyarthralgia persisted. Additional information has been requested.
Age: 4.0
Sex: F
Vaccine: HEP, MMR
Symptoms: Dysphemia
Clinical narrative: Information has been received from a registered nurse concerning a 4 year old female with no medical history who on 10-NOV-2008 was vaccinated with the first dose of MMR II (lot #660209/1119X), 0.5ml, SQ. Concomitant therapy included HEP B (lot # 660462/0599X, duration and dose not reported). There was no concomitant medication. A week later the patient began stuttering. The patient has been referred to a speech therapist, but the patient's mother has declined to take her at this time. At time of the report the patient was not recovered. The patient did not have any lab diagnostics. The patient sought medical attention by phone call. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Body temperature increased, Malaise, Pyrexia
Clinical narrative: Information has been received from a consumer concerning her child with a history of anaphylactic reaction to latex who on an unspecified date was vaccinated with a first dose of MMR II, and was severely sick and had a fever of 104 degree F. At the time of reporting, the outcome of the events were unspecified. No further information is available.
Sex: U
Vaccine: MMR
Symptoms: Convulsion, Head injury, Syncope, Tremor
Clinical narrative: Information has been received from a physician concerning a patient who was vaccinated with a dose of MMR II "years ago". It was reported that the patient stood up after an MMR II vaccination, fainted, and hit his/her head on a metal door. It was reported that the patient developed a seizure. It was reported that the patient was triaged at the office. Follow up information was received on 08-JAN-2009 from a medical assistant who reported that the physician told her this incident happened five to ten years ago. The physician could not provide any patient identifiers. The physician stated that the child did not have a seizure. It was reported that the child started to shake after hitting his/her head. The physician further stated that th incident was in no was connected to the MMR II vaccine. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Mumps antibody test negative
Clinical narrative: Information has been received from a certified medical assistant concerning an unidentified patient who on unspecified date in the past "may" have been vaccinated with a dose of MMR II. It was reported that the patient was negative for mumps antibody. It was noted that the patient did have antibody against measles and rubella. The reporter was not sure of the patient's history and she had not information regarding the patient. Follow up Information was received on 02-FEB-2009 from the certified medical assistant who stated that there was no adverse experience related to the initial report. Additional information has been requested.
Age: 5.0
Sex: F
Vaccine: MMR
Symptoms: Erythema, Local reaction, Oedema peripheral, Pruritus, Urticaria
Clinical narrative: Information has been received from a physician concerning a 5 year old "healthy" female with a history of skin irritation at injection site (onset 24-OCT-2008, after administration in the left deltoid with the fifth dose of FLUZONE (Lot #U2786aa) at 5:30 p.m. of 15-OCT-2008) who on 22-NOV-2008, at 10:30 a.m., was vaccinated with a second dose of MMR II (Lot #661679/1247X). On 26-NOV-2008, "3 days post injection", the patient developed mild localized swelling, redness and itchiness in the left arm which was "persisting onto the 9th day". The patient had a doctor visit and was diagnosed with urticaria. Additional information is not expected.
Sex: U
Vaccine: MMR
Symptoms: Psoriasis
Clinical narrative: Information has been received from a pharmacist concerning a patient who was vaccinated with MMRII. The pharmacist reported that the patient experienced psoriasis after receiving the vaccine. Additional information has been requested.
Age: 14.0
Sex: M
Vaccine: DTAP, MMR
Symptoms: Disturbance in attention, Inappropriate schedule of drug administration, Irritability
Clinical narrative: Information has been received from a caller concerning a 14 year old male patient with allergy to GEODON and a history of slight emotional difficulties who on 03-APR-1996 was vaccinated with the first dose of MMR II, on 07-NOV-1998 with the second dose and on 03-DEC-2008 subcutaneously with the third 0.5 ml dose. Concomitant therapy included LAMICTAL, SEROQUEL and DTaP. The caller reported that on 003-Dec-2008 after her son received the third dose he became irritable "snappy" and had "trouble focusing". The patient's physicians were aware of this event. At the time of reporting the patient was not recovered. Additional information has been requested.
Sex: F
Vaccine: MMR
Symptoms: Rubella antibody negative
Clinical narrative: Information has been received from an adult female consumer who in her childhood was vaccinated with a dose MMR II. In approximately January 2009 she had low titers for rubella. Her mumps and Measles titers were normal. No adverse effects noted. This is one of two reports from the same source. No further information is available.